Colombia grants emergency use approval for Pfizer-BioNTech Covid-19 vaccine

Initially, patients aged 60 years and above or those with co-morbidities like asthma and diabetes, and health workers will receive the vaccines. Credit: Sam Moqadam on Unsplash.